STAAR Surgical (STAA) News Today

STAAR Surgical Company (NASDAQ: STAA) is moving higher after reporting a strong first quarter and sparking a wave of bullish analyst reaction. The company posted a profit of $0.38 per share versus expectations of $0.13, and revenue topped estimates as well. Investors are encouraged by the turnaround from a loss a year ago, along with signs of improving demand, especially in China.

• Positive Sentiment: STAAR Surgical beat Q1 earnings and revenue expectations, with the business swinging to a profit and showing strong year-over-year improvement. Staar Surgical (STAA) Tops Q1 Earnings and Revenue Estimates
• Positive Sentiment: Wedbush upgraded STAA to Outperform and lifted its price target to $40, citing improving prospects tied to a China recovery. STAAR Surgical was upgraded by Wedbush
• Positive Sentiment: Mizuho also turned more constructive on the stock with a higher price target, reflecting better earnings momentum and outlook expectations. Mizuho Issues Positive Forecast for STAAR Surgical Stock Price
• Positive Sentiment: Commentary around the earnings call highlighted China strength, cost discipline, and stabilizing inventory as drivers of the turnaround. Staar Surgical Signals Sharp Turnaround Amid China Strength
• Neutral Sentiment: Wells Fargo raised its price target to $25 but kept an Equal Weight rating, signaling some caution despite the recent rally. STAAR Surgical had its price target raised by Wells Fargo
• Negative Sentiment: Some analysts still see limited visibility into STAAR Surgical’s 2026 outlook, and a new risk disclosure added to uncertainty around future performance and valuation. Staar Surgical Faces Heightened Uncertainty

Overall, STAA appears to be rising on the back of a meaningful earnings beat, improving operational trends, and multiple analyst upgrades/target increases, while lingering caution centers on visibility and regulatory risk.